UPI MDR delay spooks fintech stocks; Pine Labs, Paytm drop

Shares of Pine Labs, Paytm and MobiKwik fell sharply today after Inc42 reported that the planned reintroduction of merchant discount rates (MDR) on UPI transactions above ₹2,000 has been pushed from October 15 to January 2027. The deferral follows retailer pushback and comes just weeks after the Supreme Court declined to stay the fee, leaving the 0.4% levy intact.

When we covered the Supreme Court decision on 28 September, the market treated it as a quiet win for fintech platforms that rely on MDR as a revenue stream. September volumes dipped 2% month-on-month, but officials dismissed concerns that the fee would curb adoption. The latest delay, however, suggests lingering uncertainty about how the economics will settle.

For listed players like Pine Labs and Paytm, the deferral removes near-term visibility on a potential revenue line. Some market observers had suggested the fee could support payment volumes, but the delay leaves investors reassessing the outlook. The risk now is that the fee may be adjusted—or that the rollout could face further changes.

The deferral to January leaves open questions about the final structure. Watch for further retailer lobbying and potential revisions before the new rollout date.

Sources: inc42.com